Results 271 to 280 of about 45,588 (281)

Elucidation of Phosphodiesterase Type 5 Inhibitor Mechanism of Action

Journal of Urology, 2013
openaire   +2 more sources

Olprinone: A Phosphodiesterase III Inhibitor with Positive Inotropic and Vasodilator Effects

Cardiovascular Drug Reviews, 2002
Katsufumi Mizushige, Hitoshi Suzuki
exaly  

Specific type IV phosphodiesterase inhibitor ameliorates cerulein-induced pancreatitis in rats

Biochemical and Biophysical Research Communications, 2006
Michiro Otaka, Masaru Odashima, Mario Jin   +2 more
exaly  

Long-acting phosphodiesterase 5 inhibitor, tadalafil, and superoxide dismutase mimetic, tempol, protect against acute hypoxia-induced pulmonary hypertension in rats

Human and Experimental Toxicology, 2012
Anita Kotwani, M Fahim
exaly  

The phosphodiesterase 3 inhibitor ORG 9935 inhibits oocyte maturation in the naturally selected dominant follicle in rhesus macaques

Contraception, 2008
Jeffrey T Jensen, Mary B Zelinski, Richard L Stouffer   +2 more
exaly  

Phosphodiesterase 5 inhibitor, zaprinast, selectively increases cerebral blood flow in the ischemic penumbra in the rat brain

Neurological Research, 2005
Feng Gao, Hideaki Nukui
exaly  

Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage

Kidney International, 2005
Atilio Ferrebuz, Yasmir Quiroz, Hector Pons   +2 more
exaly  

Apoptosis and Nitrative Stress Associated with Phosphodiesterase Inhibitor-Induced Mesenteric Vasculitis in Rats

Toxicologic Pathology, 2003
Mudher Albassam
exaly  

Enzymological and pharmacological profile of T-0156, a potent and selective phosphodiesterase type 5 inhibitor

European Journal of Pharmacology, 2002
Hirotaka Inoue, Tsunehisa Noto, Koji Yano   +2 more
exaly  

Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study

Journal of Dermatological Treatment, 2016
exaly